Dose-Adjusted EPOCH-R is Superior to R-CHOP in Frontline Treatment of Mediastinal Large B-Cell Lymphoma

被引：0
|
作者：
Ma'koseh, Mohammad [1 ,2 ]
Yaseen, Abeer [1 ]
Abu Abed, Nebras [1 ]
Shahin, Omar [1 ,2 ]
Abufara, Alaa [1 ]
Halahleh, Khalid [1 ]
Al-Rwashdeh, Mohammad [1 ]
Rahman, Zaid Abdel [2 ]
Alyaqoub, Maram [1 ]
Al-rabi, Kamal [1 ,3 ]
Abdel-Razeq, Hikmat [1 ,3 ]
机构：
[1] King Hussein Canc Ctr, Dept Med, Amman, Jordan
[2] Univ Jordan, Coll Med, Amman, Jordan
[3] Univ Jordan, Amman, Jordan
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
ABCL; mediastinal large B-cell lymphoma; DA-EPOCH-R; R-CHOP; survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-680
引用
收藏
页码：S488 / S488
页数：1
相关论文
共 50 条
  • [1] Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma
    Malenda, Agata
    Kolkowska-Lesniak, Agnieszka
    Pula, Bartosz
    Dlugosz-Danecka, Monika
    Chelstowska, Monika
    Konska, Agnieszka
    Giza, Agnieszka
    Lech-Maranda, Ewa
    Jurczak, Wojciech
    Warzocha, Krzysztof
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (01) : 59 - 66
  • [2] Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective study
    Morgenstern, Yael
    Aumann, Shlomzion
    Goldschmidt, Neta
    Gatt, Moshe E.
    Nachmias, Boaz
    Horowitz, Netanel A.
    CANCER MEDICINE, 2021, 10 (24): : 8866 - 8875
  • [3] R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis
    Shah, Nirav N.
    Szabo, Aniko
    Huntington, Scott F.
    Epperla, Narendranath
    Reddy, Nishitha
    Ganguly, Siddhartha
    Vose, Julie
    Obiozor, Cynthia
    Faruqi, Fahad
    Kovach, Alexandra E.
    Costa, Luciano J.
    Xaiver, Ana C.
    Okal, Ryan
    Kanate, Abraham S.
    Ghosh, Nilanjan
    Kharfan-Dabaja, Mohamed A.
    Strelec, Lauren
    Hamadani, Mehdi
    Fenske, Timothy S.
    Calzada, Oscar
    Cohen, Jonathon B.
    Chavez, Julio
    Svoboda, Jakub
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (04) : 534 - 544
  • [4] Dose-adjusted EPOCH-R vs. R-CHOP in frontline management of Waldeyer's ring diffuse large B-cell lymphoma: a retrospective study from a single institution
    Liang, Yuanzheng
    Liu, Xindi
    Yang, Jing
    Wang, Henan
    Piao, Yingshi
    Wei, Liqiang
    Wang, Liang
    CHINESE MEDICAL JOURNAL, 2023, 136 (02) : 167 - 175
  • [5] Dose-adjusted EPOCH-R vs. R-CHOP in frontline management of Waldeyer’s ring diffuse large B-cell lymphoma: a retrospective study from a single institution
    Liang Yuanzheng
    Liu Xindi
    Yang Jing
    Wang Henan
    Piao Yingshi
    Wei Liqiang
    Wang Liang
    中华医学杂志英文版, 2023, 136 (02)
  • [6] Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303
    Bartlett, Nancy L.
    Wilson, Wyndham H.
    Jung, Sin-Ho
    Hsi, Eric D.
    Maurer, Matthew J.
    Pederson, Levi D.
    Polley, Mei-Yin C.
    Pitcher, Brandelyn N.
    Cheson, Bruce D.
    Kahl, Brad S.
    Friedberg, Jonathan W.
    Staudt, Louis M.
    Wagner-Johnston, Nina D.
    Blum, Kristie A.
    Abramson, Jeremy S.
    Reddy, Nishitha M.
    Winter, Jane N.
    Chang, Julie E.
    Gopal, Ajay K.
    Chadburn, Amy
    Mathew, Susan
    Fisher, Richard I.
    Richards, Kristy L.
    Schoder, Heiko
    Zelenetz, Andrew D.
    Leonard, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (21) : 1790 - +
  • [7] Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R
    Giulino-Roth, Lisa
    O'Donohue, Tara
    Chen, Zhengming
    Bartlett, Nancy L.
    LaCasce, Ann
    Martin-Doyle, William
    Barth, Matthew J.
    Davies, Kimberly
    Blum, Kristie A.
    Christian, Beth
    Casulo, Carla
    Smith, Sonali M.
    Godfrey, James
    Termuhlen, Amanda
    Oberley, Matthew J.
    Alexander, Sarah
    Weitzman, Sheila
    Appel, Burton
    Mizukawa, Benjamin
    Svoboda, Jakub
    Afify, Zeinab
    Pauly, Melinda
    Dave, Hema
    Gardner, Rebecca
    Stephens, Deborah M.
    Zeitler, William A.
    Forlenza, Christopher
    Levine, Jennifer
    Williams, Michael E.
    Sima, Jody L.
    Bollard, Catherine M.
    Leonard, John P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (05) : 739 - 747
  • [8] Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?
    Lakhotia, Rahul
    Melani, Christopher
    Roschewski, Mark
    Wilson, Wyndham H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (18) : 2063 - +
  • [9] Dose-adjusted EPOCH-R plus venetoclax: a toxic bend in the road to improving R-CHOP?
    Chamuleau, Martine E. D.
    LANCET HAEMATOLOGY, 2021, 8 (11): : E781 - E783
  • [10] Cost Analysis of R-CHOP Versus Dose-Adjusted R-EPOCH in Treatment of Diffuse Large B-Cell Lymphoma with High-Risk Features
    Bhagirathbhai Dholaria
    Yenny Alejandra Moreno Vanegas
    Nancy Diehl
    Aaron C. Spaulding
    Sue Visscher
    Han W. Tun
    Sikander Ailawadhi
    Prakash Vishnu
    Clinical Hematology International, 2020, 2 (3) : 117 - 124
12345